Pfizer (NYSE:PFE) has said that its anti-smoking drug demand has soared in Japan.
Pfizer (NYSE:PFE) Demand Soaring
According to a report, demand for the drug Chantix, manufactured by Pfizer (NYSE:PFE) which is marketed as Champix in Japan, soared when a large number of smokers decided to quit after the Japanese government, concerned about public health and needing to raise revenues, decided to hike the tax on cigarettes in October.
Kinji Iwase, Pfizer (NYSE:PFE) spokesman in Tokyo said, “An extraordinary number of people decided to quit, and our reading of the situation was off. We expected more demand, but not to this extent.”
Pfizer Inc. (NYSE:PFE) company shares are currently standing at 17.68.
If you’re contemplating investing in Pfizer Inc. (NYSE:PFE) shares, make sure you do it at the right price. Timing the market or technical analysis can be a fruitless exercise, but do make sure you take into account the historical price data:
We will be monitoring the Pfizer Inc. (NYSE:PFE) stock price for developments over the next few weeks.